A Multicenter Phase 2 Single-arm Proof-of-concept Trial to Assess the Efficacy and Safety of Ustekinumab in Association With Prednisone for the Treatment of Non-infectious Severe Uveitis (NISU)
Clinical trial NCT03847272 · TERMINATED
Trial details
- NCT number
- NCT03847272
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2023-10-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.